6-K

                                    FORM 6-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                        Report of Foreign Private Issuer

                    PURSUANT TO RULE 13a-16 or 15d-16 OF THE
                         SECURITIES EXCHANGE ACT OF 1934

        For the month of: December 2003   Commission File Number: 0-26531

                             SOIL BIOGENICS LIMITED
                    ----------------------------------------
                               (Registrant's Name)

                       P.O. Box 48525, 595 Burrard Street
                            Vancouver, Canada V7X 1A2
                    ----------------------------------------
                    (Address of Principal Executive Offices)

Indicate  by check mark whether the registrant files or will file annual reports
under  cover  of  Form  20-F  or  Form  40-F:

                        Form 20-F [X]     Form 40-F [ ]

Indicate  by check mark if the registrant is submitting the Form 6-K in paper as
permitted  by  Regulation  S-T  Rule  101(b)(1):  [ ]

NOTE:  Regulation  S-T  Rule 101(b)(1) only permits the submission in paper of a
Form  6-K  if  submitted solely to provide an attached annual report to security
holders.

Indicate  by check mark if the registrant is submitting the Form 6-K in paper as
permitted  by  Regulation  S-T  Rule  101(b)(7):  [ ]

NOTE:  Regulation  S-T  Rule 101(b)(7) only permits the submission in paper of a
Form  6-K if submitted to furnish a report or other document that the registrant
foreign  private  issuer  must  furnish  and  make  public under the laws of the
jurisdiction  in  which  the  registrant  is  incorporated, domiciled or legally
organized  (the  registrant's  "home  country"),  or under the rules of the home
country exchange on which the registrant's securities are traded, as long as the
report  or  other document is not a press release, is not required to be and has
not  been distributed to the registrant's security holders, and, if discussing a
material  event,  has already been the subject of a Form 6-K submission or other
Commission  filing  on  EDGAR.

Indicate  by  check mark whether by furnishing the information contained in this
Form,  the  registrant  is  also  thereby  furnishing  the  information  to  the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

                                 Yes [ ] No [X]



If "Yes" is marked, indicate below the file number assigned to the registrant in
connection  with  Rule  12g3-2(b):  N/A
                                    ---

Filed  with  this  Form  6-K  is  the  following which is incorporated herein by
reference:

99.1   Press release  -  December 10,  2003:  Soil  Biogenics  Limited Announces
       incorporation  of  wholly  owned  subsidiary  Soil  Biogenics  S.L.

                                   Signatures

Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on its behalf by the
undersigned,  thereunto  duly  authorized.

                                                 SOIL BIOGENICS LIMITED

Date:  December 10, 2003                    BY:  /s/ Agustin Gomez de Segura
       -----------------                         ---------------------------
                                                 Agustin Gomez de Segura
                                                 Director



                                  EXHIBIT INDEX

99.1   Press Release  -  December  10,  2003: Soil  Biogenics  Limited Announces
                         incorporation of wholly owned subsidiary Soil Biogenics
                         S.L.




                                        2

EX-99.1

                                  PRESS RELEASE

                             SOIL BIOGENICS LIMITED

NEWS RELEASE                                                   December 10, 2003


  SOIL BIOGENICS LIMITED ANNOUNCES INCORPORATION OF WHOLLY OWNED SUBSIDIARY SOIL
                                 BIOGENICS S.L.

VANCOUVER,  DECEMBER  10,  2003  -  Agustin  Gomez  de Segura, President of SOIL
BIOGENICS  LIMITED  (NASD  OTC  BB:  SOBGF) announces that it has incorporated a
wholly  owned Spanish subsidiary, Soil Biogenics S.L., to produce and market its
bio-organic  fertilizer.  The  company  will  be  based  in  Madrid,  Spain.

The  Company  decided  to  locate  its  bio-organic  fertilizer  production  and
distribution  facilities  in  Spain  due to the importance of agriculture to the
Spanish economy. In addition, Spain as a member of the European Union is ideally
situated  for  the  distribution  of  the Company's fertilizer products into the
European  Union  and  the  Mediterranean  markets.

Mr.  Agustin  Gomez  de  Segura  and Dr. Eduardo Gomez-Acebo have been appointed
directors  of  the  subsidiary.

Dr.  Gomez-Acebo, MD, MBA, has a wealth of experience in the biotechnology field
and  has  served  as  consultant  to  several  companies  involved in health and
agriculture.  He  is currently a member of the Board of Directors of NeuroPharma
and  scientific  advisor  to  the  Zeltia  Group.


ON BEHALF OF THE BOARD OF DIRECTORS

Agustin Gomez de Segura
Director


Forward-Looking  Statements

Some of the statements contained in this release are forward-looking statements,
such  as  estimates  and  statements  that  describe the Company's future plans,
objectives  or  goals,  including  words  to  the  effect  that  the  Company or
management  expects  a  stated  condition  or  result  to occur. Forward-looking
statements  may be identified by such terms as "believes", "expects", "intends",
"estimates",  "may",  "could", "would", "will", or "plan". Since forward-looking
statements are based on assumptions and address future events and conditions, by
their very nature, they involve inherent risks and uncertainties. Actual results
in  each  case  could differ materially from those currently anticipated in such
statements.  Readers  should  not  place  undue  reliance  on  the  Company's
forward-looking  statements.  The  Company  does  not  undertake  to  update any
forward-looking  statement  that may be made from time to time by the Company or
on  its  behalf,  except  in  accordance  with  applicable  securities  laws.